Literature DB >> 21273202

In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography.

Taishi Yonetsu1, Tsunekazu Kakuta, Tetsumin Lee, Kentaro Takahashi, Naohiko Kawaguchi, Ginga Yamamoto, Kenji Koura, Keiichi Hishikari, Yoshito Iesaka, Hideomi Fujiwara, Mitsuaki Isobe.   

Abstract

AIMS: The widely accepted threshold of <65 μm for coronary plaque fibrous cap thickness was derived from postmortem studies of ruptured plaques and may not be appropriate for in vivo rupture-prone plaques. We investigated the relationship between fibrous cap thickness and plaque rupture using optical coherence tomography (OCT). METHODS AND
RESULTS: We studied 266 lesions (103 from patients with acute coronary syndrome and 163 from patients with stable angina) before percutaneous coronary intervention using OCT. Ruptured and non-ruptured lipid-rich plaques were identified and the thinnest and most representative fibrous cap thickness were determined. Cap thickness was reliably measured in 71 ruptured and 111 non-ruptured plaques. From the ruptured plaques, the median thinnest cap thickness was 54 μm (50-60). The median most representative cap thickness was 116 μm (103-136). For non-ruptured plaques, the median thinnest cap thickness was 80 μm (67-104) and 182 μm (156-216) for most representative cap thickness. In 95% of ruptured plaques, the thinnest cap thickness and most representative cap thickness were <80 and <188 μm, respectively. The best cut-offs for predicting rupture were <67 μm (OR: 16.1, CI: 7.5-34.4, P < 0.001) for the thinnest cap thickness and <151 μm (OR: 35.6, CI: 15.0-84.3, P < 0.001) for most representative cap thickness. These two measures were modestly correlated (r(2) = 0.39) and both independently associated with rupture.
CONCLUSION: In vivo critical cap thicknesses were <80 μm for the thinnest and <188 μm for most representative fibrous cap thickness. Prospective imaging studies are required to establish the significance of these values.

Entities:  

Mesh:

Year:  2011        PMID: 21273202     DOI: 10.1093/eurheartj/ehq518

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  37 in total

1.  Morphologic Features of Carotid Plaque Rupture Assessed by Optical Coherence Tomography.

Authors:  S Shindo; K Fujii; M Shirakawa; K Uchida; Y Enomoto; T Iwama; M Kawasaki; Y Ando; S Yoshimura
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-13       Impact factor: 3.825

2.  Intravascular Polarimetry in Patients With Coronary Artery Disease.

Authors:  Kenichiro Otsuka; Martin Villiger; Antonios Karanasos; Laurens J C van Zandvoort; Pallavi Doradla; Jian Ren; Norman Lippok; Joost Daemen; Roberto Diletti; Robert-Jan van Geuns; Felix Zijlstra; Gijs van Soest; Jouke Dijkstra; Seemantini K Nadkarni; Evelyn Regar; Brett E Bouma
Journal:  JACC Cardiovasc Imaging       Date:  2019-08-14

3.  Three-dimensional morphological response of lipid-rich coronary plaques to statin therapy: a serial optical coherence tomography study.

Authors:  Zhao Wang; Young-Seok Cho; Tsunenari Soeda; Yoshiyasu Minami; Lei Xing; Haibo Jia; Aaron Aguirre; Rocco Vergallo; Hang Lee; James G Fujimoto; Bo Yu; Ik-Kyung Jang
Journal:  Coron Artery Dis       Date:  2016-08       Impact factor: 1.439

Review 4.  Imaging the event-prone coronary artery plaque.

Authors:  Andreas A Giannopoulos; Dominik C Benz; Christoph Gräni; Ronny R Buechel
Journal:  J Nucl Cardiol       Date:  2017-07-06       Impact factor: 5.952

Review 5.  Optical Coherence Tomography For the Detection of the Vulnerable Plaque.

Authors:  Konstantinos Toutouzas; Antonios Karanasos; Dimitris Tousoulis
Journal:  Eur Cardiol       Date:  2016-12

Review 6.  New insights into the vulnerable plaque from imaging studies.

Authors:  Robert S Fenning; Robert L Wilensky
Journal:  Curr Atheroscler Rep       Date:  2014-03       Impact factor: 5.113

7.  Usefulness of pre- and post-stent optical frequency domain imaging findings in the prediction of periprocedural cardiac troponin elevation in patients with coronary artery disease.

Authors:  Kenichiro Otsuka; Kenei Shimada; Hirotoshi Ishikawa; Haruo Nakamura; Hisashi Katayama; Hisateru Takeda; Kohei Fujimoto; Noriaki Kasayuki; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

8.  Lipid-lowering therapy stabilizes the complexity of non-culprit plaques in human coronary artery: a quantitative assessment using OCT bright spot algorithm.

Authors:  Yoshiyasu Minami; Taylor Hoyt; Jennifer E Phipps; Thomas E Milner; Lei Xing; Hang Lee; Bo Yu; Marc D Feldman; Ik-Kyung Jang
Journal:  Int J Cardiovasc Imaging       Date:  2016-12-16       Impact factor: 2.357

Review 9.  Clinical classification of plaque morphology in coronary disease.

Authors:  Fumiyuki Otsuka; Michael Joner; Francesco Prati; Renu Virmani; Jagat Narula
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

10.  Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques.

Authors:  Jagat Narula; Masataka Nakano; Renu Virmani; Frank D Kolodgie; Rita Petersen; Robert Newcomb; Shaista Malik; Valentin Fuster; Aloke V Finn
Journal:  J Am Coll Cardiol       Date:  2013-03-12       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.